Latest filing published 10 Mar 2026 for Viatris Inc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark W. Parrish, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Omnicell, Inc., Mylan II B.V. and Viatris Inc. Over a trading history stretching from 17 March 2016 to 6 March 2026, the count stands at 43 filings.
The open-market side counts 2 purchases for €246k alongside 1 sale for €538k. On balance, insiders were net sellers of €292k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 18 share grants and 21 option exercises.
On 10 March 2026 came the latest disclosure, an option exercise in Viatris Inc. The most recent open-market purchase was published on 12 August 2020, 2,260 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations